Bethyl Laboratories
Human TNF alpha ELISA KitNew
ELISA Kits
Catalog #E82-009
TargetHuman TNF alpha
ReactivityHuman
ApplicationELISA
Image 1 of 1
local_shipping
Please allow 3-5 business days for shipment.
Product Description
TNF-alpha is a multifunctional proinflammatory cytokine that belongs to the tumor necrosis factor (TNF) superfamily. TNF-alpha can bind to, and thus functions through its receptors TNFRSF1A/TNFR1 and TNFRSF1B/TNFBR. It is mainly secreted by macrophages and is involved in the regulation of a wide spectrum of biological processes including cell proliferation, differentiation, apoptosis, lipid metabolism, and coagulation. TNF-alpha has been implicated in a variety of diseases, including autoimmune diseases, insulin resistance, psoriasis, rheumatoid arthritis ankylosing spondylitis, tuberculosis, autosomal dominant polycystic kidney disease, and cancer. [taken from NCBI Entrez Gene (Gene ID: 7124)].
Specifications
Reactivity
Human
Target Identity
TargetHuman TNF alpha
Gene ID7124
Gene Symbol
TNF
Gene Name
tumor necrosis factor
Uniprot IDP01375
Protein Name
Tumor necrosis factor
Alternate Names
Product Information
Applications
ELISA
Assay Type
Sandwich ELISA
Assay Range
24.58 pg/ml - 6000 pg/ml
Sample Type
Serum, Plasma, & Cell Culture Supernatant
Detection Method
Biotinylated-Streptavidin-HRP
Storage Conditions
2 - 8 °C
Shelf Life
6 months from date of receipt
Contents
- Human TNF alpha Pre-Coated 96-well Strip Plate, 1 each
- Human TNF alpha Standard vial, 2 each
- Human TNF alpha Detection Antibody
- Assay Diluent(s)
- Streptavidin-HRP Solution, 200µl
- TMB Substrate, 12 ml
- Stop Solution, 12 ml
- 20X Wash Buffer, 25 ml
- Sealing Tape, 2 sheets
Country of Origin
USA
Documents
Safety Data SheetPDF · E82-009Open
Product DatasheetPDF · E82-009 · Lot 250811 (current lot)Open
Services
Antibody Conjugation
Antibody and conjugate formats developed together, built to your specification.
Request CustomizationCustom Monoclonal Antibody Discovery Services
Full custom monoclonal development, from immunization through validation.
Explore Monoclonal DevelopmentVHH Discovery
Single-domain antibodies for structurally difficult targets a conventional monoclonal can't reach.
Explore VHH DiscoveryResources
1



